NCT05827965

Brief Summary

Intermittent Ramadan fasting was associated with a risk of complications in patients with adrenal insufficiency. A risk stratification with recommendations (lifestyle and drug adjustment) for fasting in these patients has been recently published. So, this prospective interventional study was carried out to evaluated these recommendations. Patients with secondary adrenal insufficiency and willing to fast Ramadan were included. Before Ramadan, patients underwent a clinical examination and were educated for lifestyle measures and the schedule of glucocorticoid replacement therapy was adjusted. The occurrence of complications and the number of fasted days during the month of Ramadan 2023 were reported and compared with those of Ramadan 2022.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 12, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 25, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

February 13, 2025

Status Verified

February 1, 2025

Enrollment Period

10 months

First QC Date

April 12, 2023

Last Update Submit

February 12, 2025

Conditions

Keywords

secondary adrenal insufficiencyintermittent fastingcomplicationseducationglucocorticoid replacement therapylifestyle

Outcome Measures

Primary Outcomes (2)

  • number of fasted days

    change in the number of fasted days

    one month

  • prevalence of complications

    change in the prevalece of complications

    one month

Study Arms (1)

patients with secondary adrenal insufficiency

EXPERIMENTAL

education and treatment adjustment

Behavioral: education and drug adjustement

Interventions

education of the patients (lifestyle) and adjustement of glucocorticoid replacement schedule

patients with secondary adrenal insufficiency

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged over 18 years
  • Secondary adrenal insufficiency patients
  • Substituted with glucocorticoids for more than one year.
  • Willing to fast during the month of Ramadan 2023

You may not qualify if:

  • cardiac insufficiency,
  • respiratory insufficiency,
  • hepatic insufficiency,
  • renal insufficiency (creatinine clearance \< 60 ml/min/1.73m2),
  • advanced neoplasia,
  • undernutrition,
  • diabetes insipidus,
  • diabetes mellitus,
  • neuro-psychiatric disease,
  • infectious disease
  • chronic inflammatory disease,
  • hyperthyroidism,
  • uncontrolled hypothyroidism,
  • alcoholism,
  • diuretic intake,
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital La Rabta

Tunis, Tunisia

Location

Related Publications (7)

  • Chihaoui M, Yazidi M, Oueslati I, Khessairi N, Chaker F. Intermittent fasting in adrenal insufficiency patients: a review and guidelines for practice. Endocrine. 2021 Oct;74(1):11-19. doi: 10.1007/s12020-021-02804-z. Epub 2021 Jul 2.

    PMID: 34213700BACKGROUND
  • Chihaoui M, Chaker F, Yazidi M, Grira W, Ben Amor Z, Rejeb O, Slimane H. Ramadan fasting in patients with adrenal insufficiency. Endocrine. 2017 Jan;55(1):289-295. doi: 10.1007/s12020-016-1186-0. Epub 2016 Nov 23.

    PMID: 27878773BACKGROUND
  • Chihaoui M, Grira W, Bettaieb J, Yazidi M, Chaker F, Rejeb O, Oueslati I, Feki M, Kaabachi N, Slimane H. The risk for hypoglycemia during Ramadan fasting in patients with adrenal insufficiency. Nutrition. 2018 Jan;45:99-103. doi: 10.1016/j.nut.2017.07.014. Epub 2017 Aug 3.

    PMID: 29129244BACKGROUND
  • Hussain S, Hussain S, Mohammed R, Meeran K, Ghouri N. Fasting with adrenal insufficiency: Practical guidance for healthcare professionals managing patients on steroids during Ramadan. Clin Endocrinol (Oxf). 2020 Aug;93(2):87-96. doi: 10.1111/cen.14250. Epub 2020 Jun 15.

    PMID: 32419166BACKGROUND
  • Chihaoui M, Mimita W, Oueslati I, Rejeb O, Ben Amor Z, Grira W, Yazidi M, Chaker F. Prednisolone or hydrocortisone replacement in patients with corticotrope deficiency fasting during Ramadan result in similar risks of complications and quality of life: a randomized double-blind controlled trial. Endocrine. 2020 Jan;67(1):155-160. doi: 10.1007/s12020-019-02082-w. Epub 2019 Sep 24.

    PMID: 31552584BACKGROUND
  • Mabrouk M, Chihaoui M, Sta J, Slimane CB, Oueslati I, Yazidi M, Chaker F. Ramadan Fasting Improves Health-Related Quality of Life in Patients With Secondary Adrenal Insufficiency: A Prospective Interventional Case-Control Study. Clin Endocrinol (Oxf). 2025 Oct;103(4):523-530. doi: 10.1111/cen.15286. Epub 2025 Jun 2.

  • Chihaoui M, Mabrouk M, Oueslati I, Khessairi N, Chaker F, Yazidi M. Evaluation of therapeutic education on intermittent fasting in patients with secondary adrenal insufficiency: A clinical trial. Nutrition. 2025 Apr;132:112688. doi: 10.1016/j.nut.2025.112688. Epub 2025 Jan 14.

MeSH Terms

Conditions

Intermittent Fasting

Interventions

Educational Status

Condition Hierarchy (Ancestors)

FastingFeeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: before and after education and drug adjustement
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 12, 2023

First Posted

April 25, 2023

Study Start

March 1, 2023

Primary Completion

December 30, 2023

Study Completion

March 1, 2024

Last Updated

February 13, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

Data can be shared on reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
after the publication of this study

Locations